Table 2 IgG antibodies and microbiological surveillance of patients with candidemia and Candida colonization
| Â | Anti-Eno | Anti-Fba1 | ||||||
|---|---|---|---|---|---|---|---|---|
Microorganism | Candidemia | Candidacolonization | Candidemia | Candidacolonization | ||||
| Â | n | No. (%) positive | n | No. (%) positive | n | No. (%) positive | n | No. (%) positive |
C. albicans | 25 | 21 (84.0) | 37 | 1 (2.7) | 25 | 23 (92.0) | 37 | 2 (5.4) |
C. tropicalis | 20 | 9 (45.0) | 7 | 1 (14.3) | 20 | 16 (80.0) | 7 | 2 (28.6) |
C. parapsilosis | 21 | 18 (85.7) | 1 | 0 (0) | 21 | 19 (90.5) | 1 | 0 (0) |
C. glabrata | 10 | 7 (70.0) | 3 | 2 (66.7) | 10 | 8 (80.0) | 3 | 1 (33.3) |
C.guilliermondii | 5 | 3 (60.0) | — | — | 5 | 5 (100.0) | — | — |
Candida spp. | 20 | 15 (75.0) | 2 | 1 (50.0) | 20 | 17 (85.0) | 2 | 0 (0) |
Total | 101 | 73 (72.3)a | 50 | 5 (10.0) | 101 | 88 (87.1)b | 50 | 5 (10.0) |